ºù«ÍÞÊÓƵ

Ph.D.: Beijing Institute of Biotechnology
Research Interests: Quanbin is highly interested in leveraging the mechanism related to tumorigenesis and Parkinson's disease. He is working to develop potential therapeutics for cancer and Parkinson's disease using the lab's newly-developed nanoparticles, gectosomes.